|
|
![]() | ![]() | ![]() | ![]() |
| |||||||||
This excerpt taken from the ICI 6-K filed Mar 14, 2006. ICIs strategic matrix ICIs vision is to become the leader in formulation science, creating complex mixtures that deliver the effects valued by consumers and customers. To achieve this leadership goal, and through this create superior returns for shareholders, the Group is building a portfolio of businesses that are leaders in their respective industries, bringing together consumer understanding, outstanding knowledge of customer needs and processes, and leading edge technology platforms to provide a distinctive competitive advantage for its customers. At the last strategic review, ICIs business units were evaluated in terms of market attractiveness (e.g. financial strength and sustainability) and competitive position (e.g. quality of products, technology and market share). Reflecting their different strengths and weaknesses, each business was then mapped onto the two by two matrix shown below. This matrix is fundamental to the strategic development of the business. For example, ICI intends to invest to support growth in businesses with strong positions in high growth markets the grow aggressively segments which are more attractive in the long term. In contrast, ICI will invest to improve cost and capital effectiveness in its businesses in relatively low growth markets the maintain selectively segments with the aim of continued cost effectiveness and resilient financial performance. Examples of this approach can be found in the section that follows entitled Strategic Progress in 2005. ICIs strategy is to create and capture additional value from three principal sources:
Examples of what was achieved in 2005 can be found in the section that follows entitled Strategic Progress in 2005.
|
| |||||||